Skip to main content
×
Home
    • Aa
    • Aa

Periconception folic acid supplementation, fetal growth and the risks of low birth weight and preterm birth: the Generation R Study

  • Sarah Timmermans (a1) (a2), Vincent W. V. Jaddoe (a1) (a3) (a4), Albert Hofman (a3), Régine P. M. Steegers-Theunissen (a2) (a3) (a4) (a5) and Eric A. P. Steegers (a2)...
Abstract

Countries worldwide, including the Netherlands, recommend that women planning pregnancy use a folic acid supplement during the periconception period. Some countries even fortify staple foods with folic acid. These recommendations mainly focus on the prevention of neural tube defects, despite increasing evidence that folic acid may also influence birth weight. We examined whether periconception folic acid supplementation affects fetal growth and the risks of low birth weight, small for gestational age (SGA) and preterm birth, in the Generation R Study in Rotterdam, the Netherlands. Main outcome measures were fetal growth measured in mid- and late pregnancy by ultrasound, birth weight, SGA and preterm birth in relation to periconception folic supplementation (0·4–0·5 mg). Data on 6353 pregnancies were available. Periconception folic acid supplementation was positively associated with fetal growth. Preconception folic acid supplementation was associated with 68 g higher birth weight (95 % CI 37·2, 99·0) and 13 g higher placental weight (95 % CI 1·1, 25·5), compared to no folic acid supplementation. In these analyses parity significantly modified the effect estimates. Start of folic acid supplementation after pregnancy confirmation was associated with a reduced risk of low birth weight (OR 0·61, 95 % CI 0·40, 0·94). Similarly, reduced risks for low birth weight and SGA were observed for women who started supplementation preconceptionally, compared to those who did not use folic acid (OR 0·43, 95 % CI 0·28, 0·69 and OR 0·40, 95 % CI 0·22, 0·72). In conclusion, periconception folic acid supplementation is associated with increased fetal growth resulting in higher placental and birth weight, and decreased risks of low birth weight and SGA.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Periconception folic acid supplementation, fetal growth and the risks of low birth weight and preterm birth: the Generation R Study
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Dropbox account. Find out more about sending content to Dropbox.

      Periconception folic acid supplementation, fetal growth and the risks of low birth weight and preterm birth: the Generation R Study
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Google Drive account. Find out more about sending content to Google Drive.

      Periconception folic acid supplementation, fetal growth and the risks of low birth weight and preterm birth: the Generation R Study
      Available formats
      ×
Copyright
Corresponding author
*Corresponding author: Dr Sarah Timmermans, fax +31 10 7036815, email s.timmermans@erasmusmc.nl
References
Hide All
1Barker DJ & Clark PM (1997) Foetal undernutrition and disease in later life. Rev Reprod 2, 105112.
2Roseboom T, de Rooij S & Painter R (2006) The Dutch famine and its long-term consequences for adult health. Early Hum Dev 82, 485491.
3Wu G, Bazer FW, Cudd TA, et al. (2004) Maternal nutrition and foetal development. J Nutr 134, 21692172.
4Steegers-Theunissen RPM (1995) Maternal nutrition and obstetric outcome. In Clinical Obstetrics and Gynaecology. Preventive Care in Obstetrics, Vol. 9, pp. 431–445 [EAP Steegers, TKAB Eskes and EM Symonds, editors]. London: Baillière Tindal.
5Barker DJ (1994) Mothers, Babies and Disease in Later Life. London: BMJ Publishing Group.
6Hoet JJ & Hanson MA (1999) Intrauterine nutrition: its importance during critical periods for cardiovascular and endocrine development. J Physiol 514, 617627.
7Steegers-Theunissen RP & Steegers EA (2003) Nutrient–gene interactions in early pregnancy: a vascular hypothesis. Eur J Obstet Gynecol Reprod Biol 106, 115117.
8Waterland RA & Jirtle RL (2004) Early nutrition, epigenetic changes at transposons and imprinted genes, and enhanced susceptibility to adult chronic diseases. Nutrition 20, 6368.
9Heijmans BT, Tobi EW, Stein AD, et al. (2008) Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc Natl Acad Sci U S A 105, 1704617049.
10Tamura T & Picciano MF (2006) Folate and human reproduction. Am J Clin Nutr 83, 9931016.
11Bailey LB & Gregory JF III (1999) Folate metabolism and requirements. J Nutr 129, 779782.
12MRC Vitamin Study Research Group (1991) Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 338, 131137.
13Czeizel AE & Dudas I (1992) Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 327, 18321835.
14Hernandez-Diaz S, Werler MM, Walker AM, et al. (2000) Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med 343, 16081614.
15Hibbard BM (1964) The role of folic acid in pregnancy; with particular reference to anaemia, abruption and abortion. J Obstet Gynaecol Br Commonw 71, 529542.
16Steegers-Theunissen RP, Boers GH, Blom HJ, et al. (1992) Hyperhomocysteinaemia and recurrent spontaneous abortion or abruptio placentae. Lancet 339, 11221123.
17de Bree A, van Dusseldorp M, Brouwer IA, et al. (1997) Folate intake in Europe: recommended, actual and desired intake. Eur J Clin Nutr 51, 643660.
18Botto LD, Lisi A, Robert-Gnansia E, et al. (2005) International retrospective cohort study of neural tube defects in relation to folic acid recommendations: are the recommendations working? Br Med J 330, 571.
19Baumslag N, Edelstein T & Metz J (1970) Reduction of incidence of prematurity by folic acid supplementation in pregnancy. Br Med J 1, 1617.
20Goldenberg RL, Tamura T, Cliver SP, et al. (1992) Serum folate and foetal growth retardation: a matter of compliance? Obstet Gynecol 79, 719722.
21Iyengar L & Rajalakshmi K (1975) Effect of folic acid supplement on birth weights of infants. Am J Obstet Gynecol 122, 332336.
22Rolschau J, Date J & Kristoffersen K (1979) Folic acid supplement and intrauterine growth. Acta Obstet Gynecol Scand 58, 343346.
23Rolschau J, Kristoffersen K, Ulrich M, et al. (1999) The influence of folic acid supplement on the outcome of pregnancies in the county of Funen in Denmark. Part I. Eur J Obstet Gynecol Reprod Biol 87, 105110.
24Scholl TO, Hediger ML, Schall JI, et al. (1996) Dietary and serum folate: their influence on the outcome of pregnancy. Am J Clin Nutr 63, 520525.
25Tamura T, Goldenberg RL, Freeberg LE, et al. (1992) Maternal serum folate and zinc concentrations and their relationships to pregnancy outcome. Am J Clin Nutr 56, 365370.
26Neggers YH, Goldenberg RL, Tamura T, et al. (1997) The relationship between maternal dietary intake and infant birthweight. Acta Obstet Gynecol Scand 165, Suppl., 7175.
27Fawzi WW, Msamanga GI, Urassa W, et al. (2007) Vitamins and perinatal outcomes among HIV-negative women in Tanzania. N Engl J Med 356, 14231431.
28Ronnenberg AG, Goldman MB, Chen D, et al. (2002) Preconception homocysteine and B vitamin status and birth outcomes in Chinese women. Am J Clin Nutr 76, 13851391.
29Sinclair KD, Allegrucci C, Singh R, et al. (2007) DNA methylation, insulin resistance, and blood pressure in offspring determined by maternal periconceptional B vitamin and methionine status. Proc Natl Acad Sci U S A 104, 1935119356.
30Rosenquist TH & Finnell RH (2001) Genes, folate and homocysteine in embryonic development. Proc Nutr Soc 60, 5361.
31Jaddoe VW, Bakker R, van Duijn CM, et al. (2007) The Generation R Study Biobank: a resource for epidemiological studies in children and their parents. Eur J Epidemiol 22, 917923.
32Jaddoe VW, Mackenbach JP, Moll HA, et al. (2006) The Generation R Study: design and cohort profile. Eur J Epidemiol 21, 475484.
33Voedingsraad/Gezondheidsraad (1992) Advies inzake Foliumzuurvoorziening in relatie tot neuralebuisdefecten. Den Haag: Voorlichtingsbureau voor de Voeding.
34Voedingsraad/Gezondheidsraad (1993) Vervolgadvies inzake Foliumzuurvoorziening in relatie tot neuralebuisdefecten. Den Haag: Voorlichtingsbureau voor de Voeding.
35Verburg BO, Steegers EA, De Ridder M, et al. (2008) New charts for ultrasound dating of pregnancy and assessment of foetal growth: longitudinal data from a population-based cohort study. Ultrasound Obstet Gynecol 31, 388396.
36Hadlock FP, Harrist RB, Sharman RS, et al. (1985) Estimation of foetal weight with the use of head, body, and femur measurements – a prospective study. Am J Obstet Gynecol 151, 333337.
37Bleker OP, Buimer M, van der Post JA, et al. (2006) Ted (G.J.) Kloosterman: on intrauterine growth. The significance of prenatal care. Studies on birth weight, placental weight and placental index. Placenta 27, 10521054.
38Kloosterman GJ (1970) On intrauterine growth. The significance of prenatal care. Int J Gynaecol Obstet 8, 895912.
39Statistics Netherlands (2004) Standaard onderwijs indeling 2003. Voorburg/Heerlen: Statistics Netherlands.
40Statistics Netherlands (2004) Allochtonen in Nederland 2004. Voorburg/Heerlen: Statistics Netherlands.
41Kramer MS (1987) Determinants of low birth weight: methodological assessment and meta-analysis. Bull World Health Organ 65, 663737.
42Timmermans S, Jaddoe VW, Mackenbach JP, et al. (2008) Determinants of folic acid use in early pregnancy in a multi-ethnic urban population in The Netherlands: The Generation R study. Prev Med 47, 427432.
43Cunningham FG, Gant NF & Leveno KJ (1997) Foetal growth disorders. In Williams Obstetrics 1997, 21st ed., pp. 743764 [Cunningham FG, Gant NF and Leveno KJ, editors]. New York: Appleton and Lange.
44Palma S, Perez-Iglesias R, Prieto D, et al. (2008) Iron but not folic acid supplementation reduces the risk of low birthweight in pregnant women without anaemia: a case control study. J Epidemiol Community Health 62, 120124.
45van der Molen EF, Verbruggen B, Novakova I, et al. (2000) Hyperhomocysteinemia and other thrombotic risk factors in women with placental vasculopathy. BJOG 107, 785791.
46Nafee TM, Farrell WE, Carroll WD, et al. (2008) Epigenetic control of foetal gene expression. BJOG 115, 158168.
47Waterland RA & Michels KB (2007) Epigenetic epidemiology of the developmental origins hypothesis. Annu Rev Nutr 27, 363388.
48Pennisi E (2005) Environmental epigenomics meeting. Supplements restore gene function via methylation. Science 310, 1761.
49Kloosterman GJ (1956) Prolonged pregnancy. Gynaecologia 142, 372388.
50Kloosterman GJ & Huidekoper BL (1954) The significance of the placenta in obstetrical mortality; a study of 2000 births. Gynaecologia 138, 529550.
51van Delft M & Ketting E (2002) Anticonceptiegebruik in Nederland. Houten: Bohn Stafleu van Loghum.
52Hoggatt KJ (2003) Commentary: Vitamin supplement use and confounding by lifestyle. Int J Epidemiol 32, 553555.
53Brantsaeter AL, Haugen M, Hagve TA, et al. (2007) Self-reported dietary supplement use is confirmed by biological markers in the Norwegian Mother and Child Cohort Study (MoBa). Ann Nutr Metab 51, 146154.
54Bendich A (1991) Importance of vitamin status to pregnancy outcomes. In Micronutrients in Health and in Disease Prevention, pp. 235262 [Bendich A and Butterworch CE Jr, editors]. New York: Marcel Dekker.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

British Journal of Nutrition
  • ISSN: 0007-1145
  • EISSN: 1475-2662
  • URL: /core/journals/british-journal-of-nutrition
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords:

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 38
Total number of PDF views: 317 *
Loading metrics...

Abstract views

Total abstract views: 737 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 23rd October 2017. This data will be updated every 24 hours.